[1]王桂霞,周冬梅,李伟.血糖波动对2型糖尿病大鼠肾组织病理改变及IGF-1、MMP-2表达的影响[J].国际内分泌代谢杂志,2014,(04):217-219，224.[doi:10.3760/cma.j.issn.1673-4157.2014.04.001]
　Wang Guixia,Zhou Dongmei,Li Wei..Impacts of blood glucose fluctuation on renal pathologic changes and IGF-1, MMP-2 expression[J].International Journal of Endocrinology and Metabolism,2014,(04):217-219，224.[doi:10.3760/cma.j.issn.1673-4157.2014.04.001]
点击复制

血糖波动对2型糖尿病大鼠肾组织病理改变及IGF-1、MMP-2表达的影响()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2014年04期
页码:
217-219，224
栏目:
论著
出版日期:
2014-08-31

文章信息/Info

Title:
Impacts of blood glucose fluctuation on renal pathologic changes and IGF-1, MMP-2 expression　
作者:
王桂霞; 周冬梅; 李伟
作者单位：221000　徐州医学院研究生学院（王桂霞）；徐州医学院附属医院内分泌科（周冬梅，李伟） 　　
Author(s):
Wang Guixia; Zhou Dongmei; Li Wei.
Xuzhou MedicalCollege，Xuzhou 221000， China Corresponding author：Li Wei，Email：liwei.190@hotmail.com
关键词:
血糖波动; 糖尿病肾病; IGF-1; MMP-2
Keywords:
Blood glucose variation; Diabetic nephropathy; IGF-1; MMP-2
DOI:
10.3760/cma.j.issn.1673-4157.2014.04.001
摘要:
目的　观察血糖波动对2型糖尿病大鼠肾组织病理及胰岛素样生长因子（IGF）-1、基质金属蛋白酶（MMP）-2表达的影响。方法　将45只雄性Sprague-Dawley（SD）大鼠根据随机数字表法随机分为正常对照组（N组，n =10）和糖尿病模型组（DM组，n =35）。糖尿病模型组给予高糖、高脂饲料4周后，腹腔注射链脲佐菌素（STZ）35 mg/kg诱导建立2型糖尿病大鼠模型。造模成功的糖尿病大鼠根据随机数字表法随机分为持续高血糖组（C组，n =17）和血糖波动组（F组，n =17）。F组大鼠每日皮下注射普通胰岛素并错时给予葡萄糖诱导血糖波动。N组及C组予以等量生理盐水腹腔注射，F组、C组继续喂以高糖、高脂饲料，N组给予普通饲料。12周后采集尿液标本测24 h尿白蛋白，10%水合氯醛腹腔麻醉后，腹主动脉取血测血尿素氮、血肌酐、HbA1c，取肾组织行HE、PAS染色观察肾组织形态，电镜观察超微结构，免疫组织化学检测IGF-1、MMP-2的表达。结果　F组大鼠血糖波动较大，与N组、C组相比，血糖变异系数（CV值）明显升高（P ＜0.05）。与N组相比，F组、C组HbA1c水平升高，差异有统计学意义（P ＜0.05），C组与F组相比，HbA1c水平差异无统计学意义（P ＞0.05）。与C组相比，F组的尿白蛋白水平、肾脏肥大指数、肾小球硬化指数、肾小球基底膜厚度明显升高，差异均有统计学意义（P 均＜0.05）；与C组相比，F组大鼠肾组织IGF-1表达增多，MMP-2表达减少（P 均＜0.05）。结论　血糖波动可加重糖尿病肾病进展，其机制可能与上调IGF-1及下调MMP-2表达有关。
Abstract:
Objective　To investigate the impacts of blood glucose fluctuation on renal pathologic changes and IGF-1，MMP-2 expression. Methods　Forty five male Sprague-Dawley（SD） rats were divided into two groups according to random number table method：experimental group（DM group，n =35） and normal control group（N group，n =10）. Streptozotocin（35 mg/kg） was used to induce diabetes. SD rats were fed with high sugar and high fat diet for 4 weeks，and then were divided into fluctuating blood glucose group（F group，n =17） and continuous high blood glucose group（C group，n =17 ）. The rats in F group were given intraperitoneal injection of insulin and glucose at different time points every day. The same volume of physiological saline was given to rats in C and N group. High sugar and high fat diets were maintained in rats in F and C group，while ordinary diet were given to the rats in N group. 12 weeks later，24 hours urine protein，blood urea nitrogen，serum creatinine were determined，HE and PAS staining were used to observe the renal morphology，and electron microscopy was applied to observe the ultrastructural change of kidney. Expression of IGF-1 and MMP-2 were determined by immunohistochemistry.Results　Rats of F group suffered more serious blood glucose fluctuation with CV value significantly higher than that in rats of C and N group. No significant difference of HbA1c between rats of F and C group，while both higher than rats of N group. Compared with C group，rats in F group showed higher 24 hours urinary protein， kidney hypertrophy index，glomerulosclerosis index，thicker of glomerular basement membrane，and greater elevation of IGF-1 expression，while less MMP-2 expression（all P ＜0.05）. Conclusions　 Blood glucose fluctuation may aggravate diabetic kidney damage，the mechanism of which may be related to the upregulation of IGF-1，while downregulation of MMP-2.

参考文献/References:

　[1]　Service FJ.Glucose variability[J].Diabetes，2013，62（5）：1398-1404. 　
[2]　Brownlee M，Hirsch IB.Glycemic variability：a hemoglobin A1c-independent risk factor for diabetic complications[J].JAMA，2006，295（14）：1707-1708. 　
[3]　周冬梅，李伟.血糖波动对1型糖尿病大鼠肾组织基质金属蛋白酶9和金属蛋白酶1组织抑制剂表达的影响[J].中华肾脏病杂志， 2011，27（2）：130-131. 　
[4]　Lenz O，Elliot SJ，Stetler-Stevenson WG.Matrix metalloproteinases in renal development and disease[J].Am Soc Nephrol，2000，11（3）： 574-581. 　
[5]　Isshiki K，He Z，Maeno Y，et al.Insulin regulates SOCS2 expression and the mitogenic effect of IGF-1 in mesangial cells[J].Kidney Int， 2008，74（11）：1434-1443. 　
[6]　杨涛，陈家伟，刘超，等.洛伐他汀对人肾小球系膜细胞胰岛素样生长因子-1表达的影响[J].中国药科大学学报，2003，34（6）：524-528. 　
[7]　Levin-Iaina N，Iaina A，Raz I.The emerging role of NO and IGF-1 in early renal hypertrophy in STZ-induced diabetic rats[J].Diabetes Metab Res Rev，2011，27（3）：235-243. 　
[8]　Thrailkill KM，Clay Bunn R，Fowlkes JL.Matrix metallopro-teinases：their potential role in the pathogenesis of diabetic nephropathy[J]. Endocrine，2009，35（1）：1-10. 　
[9]　Lupia E，Elliot SJ，Lenz O，et al.IGF-1 decreases collagen degra-dation in diabetic NOD mesangial cells：implications for diabetic nephropathy[J].Diabetes，1999，48（8）：1638-1644.
[10]　Zhang D，Bar-Eli M，Meloche S，et al.Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor：the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals[J].Biol Chem，2004，279（19）：19683-19690.

相似文献/References:

[1].2007年糖尿病新进展学习班将举办[J].国际内分泌代谢杂志,2007,(04):226.
[2]李英,段惠军.Raf/MEK/ERK信号转导通路在糖尿病肾病发生发展中的作用[J].国际内分泌代谢杂志,2007,(04):264.
[3]张红 章向成 朱大龙.炎性反应与糖尿病肾病[J].国际内分泌代谢杂志,2015,(01):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
　Zhang Hong*,Zhang Xiangcheng,Zhu Dalong..Role of inflammation in diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
[4]邵滢,王秋月.Mir-217/Sirt1通路与糖尿病肾病[J].国际内分泌代谢杂志,2015,(02):124.[doi:10.3760/cma.j.issn.1673-4157.2015.02.014]
　Shao Ying,Wang Qiuyue..Mir-217 / Sirt1 pathway and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):124.[doi:10.3760/cma.j.issn.1673-4157.2015.02.014]
[5]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
　Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[6]任慧雯,王秋月.Epac-Rap1与糖尿病肾病[J].国际内分泌代谢杂志,2015,(03):170.[doi:10.3760/cma.j.issn.1673-4157.2015.03.007]
　Ren Huiwen,Wang Qiuyue..Epac-Rap1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):170.[doi:10.3760/cma.j.issn.1673-4157.2015.03.007]
[7]邵滢,王秋月.MiRNA-150与糖尿病肾病[J].国际内分泌代谢杂志,2015,(03):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
　Shao Ying,Wang Qiuyue..MiRNA-150 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
[8]陈堃,刘超,陈国芳,等.糖尿病肾病诊断标志物研究进展[J].国际内分泌代谢杂志,2015,(03):176.[doi:10.3760/cma.j.issn.1673-4157.2015.03.009]
　Chen Kun,Liu Chao,Chen Guofang,et al.Urinary biomarkers for diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):176.[doi:10.3760/cma.j.issn.1673-4157.2015.03.009]
[9]任慧雯,王秋月.Vasohibin-1与糖尿病肾病[J].国际内分泌代谢杂志,2015,(04):246.[doi:10.3760/cma.j.issn.1673-4157.2015.04.008]
　Ren Huiwen,Wang Qiuyue..Vasohibin-1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):246.[doi:10.3760/cma.j.issn.1673-4157.2015.04.008]
[10]安丽,王秋月.Visfatin与胰岛素抵抗及糖尿病肾病的发病机制[J].国际内分泌代谢杂志,2015,(04):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]
　An Li,Wang Qiuyue..Visfatin in the pathogenesis of insulin resistance and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]

备注/Memo

备注/Memo:
通信作者：李伟，Email: liwei.190@hotmail.com
更新日期/Last Update: 2014-07-20